Published in Drug Law Weekly, November 14th, 2006
This represents an increase of 43% and 42% over second quarter and 6 months of fiscal 2006, respectively. Net income grew to $2.3 million and $7.3 million in the second quarter and 6 months of fiscal 2007, respectively, as compared to a net loss of $4.8 million and $3.2 million during the corresponding periods of fiscal 2006.
Daniel H. Movens, Caraco's CEO, said,...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Law Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.